Bausch Health Companies (BHC) Cash from Operations (2009 - 2026)

Bausch Health Companies has disclosed Cash from Operations across 18 years of filings, most recently posting $670.0 million for Q2 2026.

• In Q2 2026, Cash from Operations rose 131.83% year-over-year to $670.0 million; the TTM figure through Jun 2026 stood at $1.8 billion (up 19.52% YoY), while the FY2025 annual figure was $1.4 billion, down 12.34% from the prior year.
• Cash from Operations came in at $670.0 million for Q2 2026 at Bausch Health Companies, up from $230.0 million in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of $670.0 million in Q2 2026 to a low of -$1.3 billion in Q3 2022.
• Average Cash from Operations over 5 years is $233.4 million, with a median of $285.5 million recorded in 2023.
• The largest YoY upside for Cash from Operations was 1879.17% in 2022 against a maximum downside of 323.94% in 2022.
• Over 5 years, Cash from Operations stood at $475.0 million in 2022, then slipped by 17.89% to $390.0 million in 2023, then surged by 54.1% to $601.0 million in 2024, then declined by 17.64% to $495.0 million in 2025, then jumped by 35.35% to $670.0 million in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were $670.0 million in Q2 2026, $230.0 million in Q1 2026, and $495.0 million in Q4 2025.